A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

Kidney disease occurs when the kidneys cant filter blood properly leading to various complications Read on to learn signs ...

More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

The analysis indicates that while potatoes don't raise heart disease risk, fried varieties may contribute to higher ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...